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Abstract:  Alzheimer’s  disease  (AD)  is  characterized  by  the  abnormal  aggregation  of 
amyloid-β peptide (Aβ) in extracellular deposits known as senile plaques.  The tyrosine 
residue  (Tyr-10)  is  believed  to  be  important  in  Aβ-induced  neurotoxicity  due  to  the 
formation of tyrosyl radicals. To reduce the likelihood of cross-linking, here we designed 
an  Aβ-40  analogue  (Aβ-40  Y10F)  in  which  the  tyrosine  residue  was  substituted  by  a 
structurally similar residue, phenylalanine. The aggregation rate was determined by the 
Thioflavin  T  (ThT)  assay,  in  which  Aβ-40  Y10F  populated  an  ensemble  of  folded 
conformations  much  quicker  and  stronger  than  the  wild  type  Aβ.  Biophysical  tests 
subsequently confirmed the results of the ThT assay, suggesting the measured increase of  
β-aggregation  may  arise  predominantly  from  enhancement  of  hydrophobicity  upon 
substitution and thus the propensity of intrinsic β-sheet formation. Nevertheless, Aβ-40 
Y10F exhibited remarkably decreased neurotoxicity compared to Aβ-40 which could be 
partly due to the reduced generation of hydrogen peroxide. These findings may lead to 
further understanding of the structural perturbation of Aβ to its fibrillation. 
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1. Introduction 
Alzheimer’s  disease  (AD),  the  principal  cause  of  dementia,  is  characterized  by  neuronal 
degeneration, synaptic loss, the presence of senile plaques (SPs), and neurofibrillary tangles (NFTs). 
Extracellular  SPs  are  composed  of  an  amyloid-β-(Aβ)-containing  core  surrounded  by  activated 
microglia, fibrillary astrocytes, and dystrophic neuritis [1]. Aβ is derived via proteolytic cleavage of a 
ubiquitous  transmembrane  protein,  termed  the  amyloid  precursor  protein  (APP),  by  the  action  of  
β- and -secretases [2,3]. The β-amyloid cascade theory stipulates a central role of Aβ production, 
oligomerization  and/or  fibrillogenesis  in  triggering  a  cascade  of  cellular  and  molecular  events  
leading to the process of synaptic failure, synapse loss, neuronal loss and eventually the occurrence  
of AD [1,4]. 
Aβ aggregates, including oligomers, protofibrils and fibrils, are believed to be the main causes that 
lead to AD [5]. Although no clear correlation has been drawn between the density of deposits and the 
severity of AD, previous findings by our group and other investigators suggest a negative correlation 
between the level of Aβ fibrils and cognitive impairment [6–9]. More and more evidence indicates that 
oligomers or protofibrils rather than Aβ plaques, contribute to early dendritic and synaptic injury and 
thereby neuronal dysfunction [10,11]. 
The  generation  of  reactive  oxygen  species  (ROS)  has  been  linked  with  Aβ  neurotoxicity  and 
neurodegeneration in AD [4,12,13]. Among the proposed mechanisms involving Aβ-induced oxidative 
stress, tyrosine is proposed to be a critical residue for its susceptibility to oxidation, especially under 
condition of oxidative stress [12,13]. An Aβ peptide with tyrosine-10 replaced by alanine is reported to 
be non-toxic and unable to induce oxidative stress responses in cells [14]. The tyrosine residue of Aβ 
could form a stable tyrosyl radical during metal catalyzed oxidation (MCO), since the proximity of 
tyrosine to the neighboring histidine residues allows redox active metal ions to receive an electron to 
form a tyrosine radical [15]. 
Due to the comparative stability of tyrosyl radicals, tyrosine has been considered to be important in 
Aβ-induced  neurotoxicity,  the  formation  of  Aβ  aggregation  and  amyloid  plaques  [16].  Here  we 
synthesized  an  Aβ-40  analogue  termed  Aβ-40  Y10F  (tyrosine  10  replaced  by  phenylalanine)  and 
explored its aggregate and neurotoxic properties. Our results indicate that the residue substitution led 
to an increased percent of peptides undertaking a β-sheet rich conformation but a dramatic decrease in 
neurotoxicity. These data may shed light upon the role of  the tyrosine residue in Aβ folding and 
neurotoxicity, and also provide further evidence for the structural perturbation of Aβ to its fibrillation. 
2. Results and Discussion 
2.1. Secondary Structural Changes of Aβ (1–40) Y10F 
AD is characterized by the formation of amyloid deposits composed primarily of Aβ [17,18], a 
natively unfolded protein with little or no ordered structure under physiological conditions [19,20]. Int. J. Mol. Sci. 2012, 13  5326 
 
 
Thus, the conditions that decrease the net charge or increase the hydrophobicity could be expected to 
result in partial folding. Previous studies suggest that the formation of Aβ dimers through the phenolic 
coupling of tyrosine (termed dityrosine-linkage) could be an early event critical to fibril formation and 
Aβ deposits in AD [15,16]. Murakami and colleagues reported that Aβ-42 Y10F shows significantly 
attenuated neurotoxicity compared to that of wild type Aβ-42 [21]. Other reports suggest that the 
substitution of tyrosine with alanine in the Aβ sequence inhibits the ability of this peptide to catalyze 
the production of H2O2 and to cross-link, as well as inhibiting Aβ neurotoxicity [14]. For these reasons, 
tyrosine 10 in the chain of Aβ is believed to be critical in the process of AD pathogenesis. 
In order to investigate the relationship between amino acid residues of Aβ-40 and conformational 
changes, our approach was firstly to record  circular dichroism (CD) spectra in the far UV region  
(190–240 nm) to detect the secondary structures of wild type and mutant peptides. The CD spectrum of 
wild  type  Aβ-40  was  characterized  by  a  strong  negative  CD  band  in  the  195-  to  200-nm  region  
(Figure 1A), indicative of a disordered or random-coil secondary structure [8]. In contrast, the spectral 
curve of Aβ-40 Y10F displayed a β-sheet spectrum as characterized by a minimum at 220 nm and a 
positive ellipticity at ~200 nm (Figure 1B). 
Figure  1.  UV  region  circular  dichroism  (CD)  spectra  of  various  Aβ  peptides.  Molar 
ellipticity of wild type Aβ-40 (A) and Aβ-40 Y10F (B) was recorded in the UV region 
(190–240 nm). Aβ peptides were diluted using 10 mM phosphate buffer (pH 7.4) to a final 
concentration of 50 µM in each sample. The average data of six run is shown. 
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2.2. Aggregation of Wild Type Aβ (1–40) and Aβ-40 Y10F 
Aggregation is a characteristic property of partially folded proteins and most aggregating protein 
systems probably involve a transient partly folded intermediate as the key precursor of fibrillation [22]. 
To confirm that the Aβ-40 Y10F-induced CD spectrum alteration was directly related to changes in the 
protein conformation, we performed a kinetic aggregation study to explore the effect of Y10 on the 
aggregative  ability  through  beta-sheet  formation  of  Aβ-40.  The  β-aggregation  of  either  wild  type  
Aβ-40 or Aβ-40 Y10F was assessed using the fluorescent dye ThT. Both type of peptides exhibited a 
gain in fibril, as evident by an increase in ThT fluorescence during the time course. As shown in 
Figure 2, it was interesting to note that the aggregation of Aβ-40 Y10F showed a more pronounced rise 
than that of wild type Aβ-40, which could be due to the secondary structural changes of modified Aβ, 
leading to a greater binding capacity for ThT or an increase in the total amount of aggregation. The 
aggregation of wild type Aβ-40 reached a steady state at around 60 h, while Aβ-40 Y10F remained in a 
rapid growth phase until 72 h, suggesting a higher aggregation ability of Aβ-40 Y10F compared to that 
of wild-type Aβ-40. 
Figure 2. Kinetic measurements of β-aggregation resulting from incubation of wild type 
Aβ-40 and Aβ-40 Y10F. ThT assay was performed with 10 µM Aβ, 10 µ M ThT and 10 mM 
phosphate buffer at 37 °C . ThT fluorescence was monitored at an excitation of 450 nm and 
emission of 485 nm. Each point represents the average of six independent experiments. 
 
Further, peptides were separately incubated at 37 ° C without agitation and allowed to fibrillize for 
72 h to investigate the aggregation state of Aβ-40 and Aβ-40 Y10F. Both peptides presented fibrillar 
morphologies though aggregates formed in wild type Aβ-40 apparently consists of shorter fibrils and 
associate laterally with each, while Aβ-40 Y10F gave rise to longer mature fibrils (long, rigid, and 
extended fibrils that could be longer than 2 µm in length) and small amounts of spherical structures 
(Figure 3B). TEM analysis of the fractions of wild type Aβ-40 showed the combined morphologies of 
fibrils (5–10 nm in diameter and >400 nm in length) and curvilinear aggregates (6–8 nm in diameter 
and  <200  nm  in  length)  (Figure  3A),  and  the  latter  are  consistent  with  previously  described Int. J. Mol. Sci. 2012, 13  5328 
 
 
morphologies for protofibrils that present as dispersed, curvilinear structures of 4–11 nm diameter and 
<200 nm length [22–24]. 
Figure 3. Negatively stained transmission electron micrographs of Aβ-40 (A) and Aβ-40 
Y10F (B). The peptide was diluted in phosphate buffer to 10 µM, and then incubated at  
37 ° C for 72 h before experiments. Both peptides presented fibrillar morphologies, wild 
type Aβ-40 showed the combined morphologies of fibrils (5–10 nm in diameter and 400 nm 
in length) and curvilinear protofibrils (6–8 nm in diameter and <100 nm in length), while 
Aβ-40 Y10F gave rise to longer mature fibrils (long and extended fibrils >2 µm in length). 
Scale bar: 200 nm. 
 
The key distinguishing features of protofibrillar aggregates include that they bind to amyloid-specific 
dyes,  such  as  Congo  red  and  Thioflavin-T  (ThT)  though  much  weaker  than  mature  fibrils,  and 
protofibrils are less stable than mature amyloid fibrils [23,25,26]. It is anticipated that the protofibrils 
or shorter fibrils formed in wild type Aβ-40 are a partially folded form and could be a precursor of 
fibrils, since the aggregates have contiguous hydrophobic patches on the surface and are prone to 
foster self-association and hence potentially fibrillation [27], though the structure of wild type Aβ-40 
resembles that of other reports under the same concentration of Aβ [25,26]. However, protofilaments 
as structural subunits of a mature fibril are distinctive from protofibrils [28]. Furthermore, the highly 
ordered structures such as protofibrils and Aβ-derived diffusible ligands (ADDLs) can be ―on pathway‖ 
to fibril formation (disappear upon fibril formation) or ―off pathway‖ species (they do not convert into 
fibrils) [29]. It is important to mention that the protofibrils of wild type Aβ-40 are unlikely to change 
into fibrils since the images were taken when the process of fibrillization was complete as indicated by 
the maximum ThT fluorescence (Figure 2). Since synthetic peptides have been shown to have slight 
biophysical variations in batch-to-batch preparations [30], we repeated EM experiments using three 
different  batches  of  both  peptides  to  verify  the  above  results.  Again,  we  observed  similar 
conformational patterns using various batches, suggesting that the conformation of Aβ-40 and Aβ-40 
Y10F were not due to an unusual synthesis of peptides. 
The binding of 1-Anilinonaphthaleine-8-Sulphonic Acid (ANS) to hydrophobic surfaces of protein 
is represented as enhanced fluorescence and a blue shift in the wavelength of peak emission (λmax), as Int. J. Mol. Sci. 2012, 13  5329 
 
 
illustrated by the binding of ANS to wild type Aβ-40 or Aβ-40 Y10F in Figure 4. The results revealed 
enhanced ANS fluorescence in the presence of both Aβ peptides. After binding to wild type Aβ-40, 
there was an approximately 1.5-fold increase in quantum yield and a blue shift in maximum emission 
wavelength for ANS from 506 to 490 nm. By contrast, the change in the fluorescence of ANS upon 
binding  to  Aβ-40  Y10F  was  much  more  pronounced,  with  an  approximately  2.5-fold  increase  in 
quantum yield and a blue shift in maximum emission wavelength to around 476 nm compared to 
unbound ANS, suggesting structural reorganization of Aβ in the form of more ordered folding when 
containing the tyrosine to phenylalanine substitution. 
Figure 4. Effect of variant Aβ peptides on ANS fluorescence. Fluorescence spectra were 
collected from 430 to 650 nm, with excitation at 350 nm. Solid lines symbolize unbound 
ANS in phosphate buffer, while ANS binding to Aβ-40 and Aβ-40 Y10F are represented 
by  dotted  and  dashed  lines,  respectively.  Each  point  represents  the  average  of  three 
independent experiments. 
 
2.3. Tyrosine Substitution Rendered Aβ-40 Less Toxic via Reduced Generation of Hydrogen Peroxide 
The aggregation and toxicity of Aβ highly correlates with its sequence and structure [31]. Previous 
studies demonstrated that protofibrils or oligomers, rather than Aβ fibrils, mainly contributed to early 
dendritic  and  synaptic  injury  and  thereby  neuronal  dysfunction  [11,32].  Using  a  small  molecule 
methylene  blue,  Necula  et  al.  successfully  inhibited  Aβ  oligomerization  concomitant  with  the 
promotion  of  fibrillization  [33],  suggesting  that  oligomers  and  fibril  formation  are  distinct  and 
competing  pathways.  According  to  the  above  biophysical  experiments,  Aβ-40  Y10F  displayed 
structural changes and its capability of forming β-sheet rich conformations was apparently increased.  
To investigate the correlation between the peptides’ aggregation and their physiological toxicity, either 
Aβ-40 or Aβ-40 Y10F treated cortical neurons were tested to see if residue substitution exerted effects 
on neurotoxicity. 
As determined by MTS assay, exposure to 5 µM wild type Aβ-40 for 96 h showed significantly 
stronger neurotoxicity than Aβ-40 Y10F, as the cell viability rate was reduced to ~70% (P < 0.01 
versus Vehicle, Figure 5). It is possible that the formation of an Aβ tyrosyl radical leads to increased 
oligomerization  via  the  formation  of  dityrosine-linkage  as  an  early  aggregation  step,  which  is Int. J. Mol. Sci. 2012, 13  5330 
 
 
supported by the identification of dityrosine in amyloid plaque [12]. Whilst for neurons treated with  
5 µM Aβ-40 Y10F for up to 96 h, the cell viability rate was ~93% (no significant difference versus 
Vehicle, Figure 5), suggesting a markedly decreased toxicity of Aβ-40 with a tyrosine substitution. 
This  lack of neurotoxicity  is  in  line with  Murakami’s  reports,  which  suggest the neurotoxicity  of  
Aβ-42 Y10F was significantly attenuated compared to that of wild type Aβ-42 [21]. However, the 
reduced toxicity of Aβ-40 with a tyrosine→phenylalanine substitution is contrary to previous study 
which suggests rodent Aβ-42 (R5G, Y10F, H13R) exhibits similar neurotoxicity to human Aβ-42 [34]. 
The reason for the discrepancy could probably be attributed to several factors such as differences with 
the type of peptide employed (various amino acid sequences) or differences in peptide aggregate forms, 
concentrations, etc.  
Figure 5. Neurotoxicity of variant Aβ peptides. Primary neuronal cells were grown for  
7  days  in  vitro,  and  then  neurons  were  exposed  to  various  Aβ  peptides  at  the  final 
concentration of 5 µM  for 96 h. Cell viability was determined by measuring the reduction 
of  MTS.  Data  are  presented  as  the  mean  ±   S.E.M.  of  three  independent  experiments. 
Student’s t test was applied to determine the significance, denoted as ** P < 0.01. 
   
Figure 6. H2O2 production induced by wild type Aβ-40 or Aβ-40 Y10F. Primary cortical 
neurons were exposed to 5 µM wild type Aβ-40 or Aβ-40 Y10F for 96 h. Absorbance 
readings were taken and compared to vehicle (Student’s t test, ** P < 0.01, n = 3). 
 
Aβ has been shown to induce protein oxidation and lipid peroxidation [35,36], while the phenol 
hydroxyl group of tyrosine (a crucial residue involved in oxidative stress) is easily oxidized through 
metal ions to give a tyrosyl radical [12]. However, the mechanism of its formation at the molecular Int. J. Mol. Sci. 2012, 13  5331 
 
 
level has not fully been clarified. To investigate the contribution of tyrosine to the generation of free 
radicals, the amount of H2O2 produced by wild type Aβ-40 or Aβ-40 Y10F was examined. As shown 
in Figure 6, Aβ-40 Y10F produced fairly low levels of H2O2 as compared to wild type Aβ-40. These 
results, together with those of the cell viability assay suggest that the Aβ-40 Y10F induced low level of 
H2O2 generation could partly account for its low cytotoxicity provided that H2O2 is not the sole factor 
responsible  for  Aβ-induced  toxicity,  confirming  that  tyrosyl  radicals  play  a  critical  role  in  the  
radical-mediated neurotoxicity of Aβ-40 [15]. 
3. Experimental Section  
3.1. Materials 
All cell culture reagents were obtained from Invitrogen (Carlsbad, USA). 1-anilinonaphthaleine-8-
sulphonic  acid  (ANS)  was  obtained  from  Cayman  Chemical  Company  (Michigan,  USA).  
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), poly-L-lysine, thioflavin T (ThT), and dimethyl sulfoxide 
(DMSO) were purchased from Sigma-Aldrich (St. Louis, MO, USA).  CellTiter 96
® Aqueous One 
Solution Reagent was procured from Promega (Madison, WI, USA). All other chemical reagents were 
commercial products of analytical grade and the highest purity available. 
3.2. Peptide Preparation 
Wild type Aβ-40 and Aβ-40 Y10F were synthesized by employing solid phase Fmoc chemistry and 
produced  by  Biosynthesis  Biotech  Co.,  Ltd,  Beijing,  China.  After  removal  from  the  resin  and  
de-protection, samples were purified and characterized by reverse phase HPLC using UV/Vis detection, 
and the purity of all peptides used was at least 95%. The lyophilized peptides were initially dissolved 
in HFIP to a final concentration of 1 mg/mL, shaken for 2 h at 4 °C  to entirely dissolve the peptide, 
then aliquoted into siliconized tubes and stored at −80 °C  [20]. Prior to experiment, the stock solution 
was spin-vacuumed using the Integrated Speed-Vac System (Thermo Savant, USA) then diluted in 10 
mM phosphate buffer (pH 7.4) to the required concentration.  
3.3. Circular Dichroism Spectroscopy 
Secondary structural changes in peptides were detected using CD spectroscopy [8,20]. The stock 
peptide  was  spin-vacuumed  then  dissolved  in  10  mM  phosphate  buffer  (pH  7.4),  and  the  final 
concentration of Aβ in each sample was 50 µM. All measurements were performed in quartz cuvette 
cells with a pathlength of 1 mm and scanned with a J-810 CD spectropolarimeter (Jasco, Japan). CD 
measurements  were  carried  out  between  190  and  240  nm  using  the  following  parameters:  2-nm 
bandwidth, 20 nm/min run speed, 0.5-nm step size, and 2-s response time. Background values for each 
test were subtracted from the corresponding CDs of each sample, and the spectra were smoothed using 
the Jasco software FFT filter function and converted to molar ellipticity. 
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3.4. Fluorescence Spectroscopy (ThT Assay) 
The  relative  degree  of  β-aggregation  is  determined  by  ThT  that  specifically  binds  to  fibrillar 
structures [37,38]. Aβ stock solution was diluted in phosphate buffer to 10 µM, ThT was then added to 
each sample to a final concentration of 10 µM. Each sample was measured in terms of fluorescence 
intensity at 37 °C  using a Varioskan multimode microplate spectrophotometer (Thermo, USA) under 
kinetic fluorometric mode. Measurements were performed every 2 h at an excitation wavelength of 
450  nm  and  an  emission  of  485  nm  [8,20].  To  account  for  the  background  fluorescence,  the 
fluorescence intensity measured from each control solution without Aβ peptide was subtracted from 
that of each solution containing Aβ. 
3.5. Transmission Electron Microscopy 
The solution of 10 µM Aβ peptide diluted in phosphate buffer was incubated at 37 °C  for 72 h. 
Each sample was spotted onto glow discharged carbon-coated 300 mesh copper grids (Ted Pella Inc., 
Redding,  CA,  USA)  for  1  min,  dried,  and  then  negatively  stained  with  2%  uranyl  acetate  [39].  
The excess was wiped off, and the grid was allowed to dry. Specimens were then examined with a 
JEM-1400 electron microscope (JEOL, Japan) at 80 kV accelerating voltage. 
3.6. 1-Anilinonaphthaleine-8-Sulphonic Acid (ANS) Binding 
ANS is a fluorescent dye that binds with high affinity to hydrophobic surfaces of proteins. The 
emission maximum of ANS undergoes a blue shift and increases significantly upon binding to the 
hydrophobic portions [40,41]. We measured ANS fluorescence to monitor structural changes in Aβ-40 
and Aβ-40 Y10F upon 4 d aging. The final concentration of peptide in the solution was 10 μM, and the 
[ANS]/[Aβ] ratio in the following experiments was kept equals to 5. Emission spectra were recorded 
from 430 to 650 nm with excitation at 350 nm. 
3.7. Primary Neuronal Cultures 
Cortical neuronal cultures were performed as described previously with some modifications [9]. 
Briefly,  embryonic  day  17  Sprague  Dawley  rat  cortices  were  dissociated  and  suspended  in  fresh 
neurobasal medium plus 2% B27 supplements, 1% penicillin-streptomycin, and 0.5 mM L-glutamine, 
then plated onto poly-L-lysine-coated 96-well culture plates at a density of 5 ×  10
4 cells per well. This 
method resulted in cultures highly enriched for neurons (>95% purity) with minimal astrocyte and 
microglial contents. The neuronal cells were allowed to mature for 7 days in vitro before commencing 
treatment. For treatment, samples were diluted to a concentration of 5 µM in serum-free neurobasal 
medium, aged for 72 h, and finally added to the cultures for 96 h. 
3.8. Cell Viability Assay 
Cell  viability  was  quantitively  determined  using  the  MTS  assay  as  described  previously  [42]. 
Briefly, cells were cultured in flat bottomed 96-well plates and exposed to various treatments. 20 µL 
CellTiter  96
®  Aqueous  One  Solution  Reagent  (MTS)  was  added  to  each  well  according  to  the Int. J. Mol. Sci. 2012, 13  5333 
 
 
manufacturer’s instructions. After 4 h in culture the cell viability was determined by measuring the 
absorbance  at  490  nm  using  a  µQuant  MQX200  reader  (Bio-Tek).  Background  readings  of  MTS 
incubated in cell-free medium were subtracted from each value before calculations. The data were 
normalized and calculated as a percentage of untreated control values prior to analysis. 
3.9. Hydrogen Peroxide Assay 
Analyses  were  carried  out  using  a  hydrogen  peroxide  assay  kit  (Beyotime  Biotech,  China)  as 
described previously [9]. Hydrogen peroxide could oxidize Fe
2+ to Fe
3+, and then Fe
3+ reacted with 
xylenol orange resulting in a colorimetric reaction that could be further detected by a spectrometer. 
Briefly, test tubes containing 50 μL of supernatants and 100 μL of test solutions were placed at room 
temperature for 20 min and measured immediately with a spectrometer at a wavelength of 560 nm.  
The  concentration  of  H2O2  released  was  calculated  from  a  standard  concentration  curve  in  
triplicate experiments. 
4. Conclusions 
In  the  present  study,  we  employed  an  Aβ-40  analogue  in  which  tyrosine  was  replaced  by  a 
phenylalanine residue. Despite its great structural similarity to tyrosine, phenylalanine is classified as 
nonpolar because of the hydrophobic nature of  its benzyl side chain. In accordance with previous 
reports [8,9,43], the folded conformation is characterized by an increased amount of ordered secondary 
structure  and  the  appearance  of  hydrophobic  clusters.  Our  results  suggest  that  wild  type  Aβ-40 
displays a far-UV CD spectrum typical of an unfolded polypeptide chain, implying the lack of ordered 
secondary  conformation  under  these  conditions,  while  the  CD  spectrum  of  Aβ-40  Y10F  was 
manifested as a dramatic increase in [θ]220 (negative CD intensity) suggesting a β-sheet structure of the 
peptide. 
Data  from  the  ThT  assay  indicated  that  both  wild  type  Aβ-40  and  Aβ-40  Y10F  exhibit  a 
fluorescence gain in a time-dependent manner [23], whereas Aβ-40 Y10F accelerated the kinetics of 
βfibril formation and resulted in a more marked rise than wild type Aβ. These results lead us to assume 
that the structure of wild type Aβ-40 consists mainly of intermediates to β-fibril (probably profibrils or 
shorter fibrils) under the current conditions, while mature fibrils are generated in solution containing  
Aβ-40 Y10F. Although this argument is admittedly speculative, the basic idea arising from this logic 
was subsequently confirmed by using TEM, in which peptides aged for 72 h were used to examine the 
aggregation state. Indubitably, Aβ-40 Y10F gives rise to longer fibrils than those formed in sample 
consisting  of  wild  type  Aβ-40.  Changes  in  ANS  fluorescence  also  confirmed  the  highly  ordered 
hydrophobic surfaces of Aβ-40 Y10F compared to that of wild type Aβ-40. Fibrillar Aβ was initially 
reported  to  facilitate  the  neuronal  cell  death  process  in  primary  rat  hippocampal  cultures,  and  
non-amyloidogenic or amorphous aggregates of Aβ are comparatively nontoxic compared with fibrillar 
Aβ  [22,31].  Interestingly,  multiple  Aβ  aggregated  species  have  been  identified,  and  neurotoxicity 
appears to be correlated with the amount of nonfibrillar oligomers  and protofibrils [6,11,44]. Our 
results confirmed the latter—that Aβ-40 Y10F led to increased βfibrils conformation rendering the 
peptide  less  toxic,  and  this  lack  of  neurotoxicity  could  be  partly  due  to  the  reduced  generation  of 
hydrogen peroxide. Int. J. Mol. Sci. 2012, 13  5334 
 
 
Former reports suggest that oligomeric fibrillization intermediates (protofibrils or oligomers), rather 
than the fibrils themselves, are pathogenic, though the mechanism by which they cause neuronal death 
remains unknown [45,46]. If Aβ oligomers or protofibrils represent the primary pathogenic species, 
then selective inhibition of these highly toxic species by blocking initial nucleation of Aβ rather than 
dissolution of amyloid fibrils or inhibiting later stages of fibrillogenesis may be an attractive means of 
therapeutic  intervention.  Studies  are  still  on  the  way  to  elucidate  the  mechanism  by  which  Aβ 
structures  are  associated  with  neurotoxicity,  though  it  seems  that  amyloid  fibrils  with  various 
structures and toxicity as well as soluble oligomers are all involved in the pathogenesis of AD in a 
complicated way. In conclusion, these data are expected to be of increasing importance in the future to 
direct or refine further model building. 
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